U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07813559) titled 'Glycoprotein IIb/IIIa PET/CT in Various GPIIb/IIIa-Related Disease' on Sept. 04.
Brief Summary: In the field of diagnosing Thrombi diseases, it is now a well established practice to inject positron-emitting tracers into the human body.
These tracers bind to specific target proteins, allowing their distribution to be visualized via PET imaging. Currently, several research groups worldwide are engaged in developing and clinically validating their own GPIIb/IIIa imaging agents.
Study Start Date: Sept. 01
Study Type: OBSERVATIONAL
Condition:
Thrombi
Thrombus, Brain
Thrombus
Intervention:
DIAGNOSTIC_TEST: 18F/68Ga-GP1
Each subje...